Pharmaceutical glass tubing finds major application in the production of parenteral drugs such as injectable, intravenous, infusion and ophthalmic preparations. Pharmaceutical glass tubing allows visual inspection of drugs and maintains the drug's stability and activity during shelf life. With rising prevalence of chronic diseases worldwide, the demand for parenteral drugs has been increasing significantly. As per findings of World Health Organization (WHO), cardiovascular diseases are the leading cause of death globally, taking an estimated 17.9 million lives each year. Similarly, cancer is projected to surpass heart disease as the leading cause of death globally by 2030. Thus, the growing disease burden is expected to propel the demand for pharmaceutical glass tubing during the forecast period.

The global pharmaceutical glass tubing Market is estimated to be valued at US$ 8.3 Bn in 2023 and is expected to exhibit a CAGR of 7.1% over the forecast period 2023 to 2030, as highlighted in a new report published by CoherentMI.

Market Dynamics:

The increasing demand for parenteral drugs owing to rising chronic disease prevalence remains a key growth driver for the global pharmaceutical glass tubing market. As per estimates, around 60% of all drugs currently in development worldwide are administered intravenously, highlighting lucrative opportunities. Additionally, technological advancements to optimize glass tubing production are supporting market growth. For instance, innovations such as tubing drawn from pre-formed sleeves instead of solid rods are helping minimize glass wastage during production. However, availability of alternative packaging such as plastic vials and prefillable syringes pose a major challenge. Stringent regulations pertaining to glass purity and testing also increases industry production costs.

SWOT Analysis:

Strength: Schott AG has a vast and experienced workforce and advanced manufacturing facilities spread globally which help meet the stringent quality standards required in pharmaceutical glass tubing products. Nipro PharmaPackaging possesses wide product portfolio to address varied needs of pharmaceutical manufacturers. Such established brands have an edge over other players.

Weakness: Frequent regulatory changes across regions add compliance burden on glass tubing makers. Also, raw material price volatility can squeeze profits of manufacturers.

Opportunity: Rising healthcare expenditure in emerging nations of Asia Pacific and Latin America will fuel demand for advanced drugs and therapies. This expands market for pharmaceutical glass tubing used in packaging vials and ampoules. Growing generics market provides scope to supply affordable parenteral products.

Threats: Stiff competition from alternative packaging materials threatens glass tubing demand. Strict regulations and lengthy approval process for new facilities limits entry of local players.

Global Pharmaceutical Glass Tubing Market Segmentation:

  • By Product Type
    • Vials
    • Ampoules
    • Cartridges
    • Syringes
    • Bottles
    • Others (Tubes, Rods, Stoppers etc.)
  •  By End User
    • Pharmaceutical
    • Biotechnology
    • Diagnostics
    • Chemical
    • Others (Research, Forensics etc.)
  •  By Distribution Channel
    • Direct Sales
    • Distributors
    • Online
    • Others
  •  By Manufacturing Process
    • Tubing
    • Molding
    • Extrusion
    • Others

Key Takeaways:

The global Pharmaceutical Glass Tubing Market Size is expected to witness high growth in the forecast period of 2023 to 2030 supported by rising pharmaceutical R&D activities and investments in medical infrastructure development globally. The global pharmaceutical glass tubing Market is estimated to be valued at US$ 8.3 Bn in 2023 and is expected to exhibit a CAGR of 7.1% over the forecast period 2023 to 2030..

Regional Analysis: Asia Pacific region is projected to dominate the market during the forecast period attributed to rapid economic development, increasing healthcare awareness and improving access to medicines in emerging countries like India, China and Indonesia. Established pharmaceutical cluster in India and growth opportunities presented by Chinese generic market are driving regional glass tubing consumption.

Key Players: Key players operating in the pharmaceutical glass tubing market are Schott AG, Nipro PharmaPackaging, Corning Incorporated and Gerresheimer AG. Schott AG dominates the global supply with its presence across Americas, Europe and Asia. Nipro PharmaPackaging is seeing increasing demand in Asia Pacific region leveraging its affordable parenteral solutions.

Get More Insights on This Topic : https://www.articledistrict.com/the-global-pharmaceutical-glass-tubing-market-growth/